#genomic medicine economics
Discover 2 curated intelligence briefings related to this specific topic.

Technology & Innovation
Warsaw and Budapest are Rewriting the Bio-Manufacturing Map
Eastern Europe has moved beyond low-cost outsourcing. A new wave of sophisticated biomanufacturing hubs is emerging, driven by an elite talent pool and a strategic push for European pharmaceutical sovereignty.
Read Analysis

Technology & Innovation
Gene Editing Just Stopped Chasing Rare Mutations
CRISPR technology is moving beyond the niche of rare genetic disorders. The focus has shifted toward common killers like cardiovascular disease and diabetes, driven by the evolution of in vivo delivery and base editing.
Read Analysis